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ABSTRACT
esistant hypertension is increasingly common 
in clinical practice and it is said to be present in Rabout one in eight patients with hypertension. 
This condition occurs when there is a failure to achieve 
target blood pressure goal despite receiving three or 
more anti-hypertensive drugs at optimal tolerable 
doses that includes a diuretic. However, renal artery 
anomaly is uncommon; its association with resistant 
hypertension is even rarer. In this case report, we 
therefore highlight the challenges in management of 
resistant hypertension and describe its unusual 
association with renal artery anomaly.
Case History:
Mr E.K a 53year old book seller who was referred to our 
nephrology clinic from a peripheral General Hospital 
on account of poorly controlled hypertension despite 
being on 3 antihypertensive including a diuretic for 3 
months. He was diagnosed hypertensive and diabetic 
8yrs and 5yrs respectively prior presentation and 
claimed to be adherent to his prescribed regimen. He 
was taking lisinopril 20mg, amlodipine 10mg,  and Co-
amilozide (Amiloride 5mg/Hydrochlothiazide 50 mg) 
1 tablet all daily. He was also taking Glucovance 
(Metformin500mg/ Glyburide 5mg) twice daily. At 
presentation in our clinic, he had no history of chest 
pain, blurring of vision or passage of frothy urine. He 
complained of occasional dry cough. There was a 
history of hypertension in his mother. He takes alcohol 
o c c a s i o n a l l y  b u t  c l a i m e d  h e  n e v e r  
smoked.Examination revealed a middle aged man who 
was obese (BMI of 33.9kg/m2), not pale and had no 
peripheral oedema. His pulse rate was 84b/min 
regular and his  blood pressure (BP) was 
208/100mmHg. His apex beat was difficult to palpate 
due to the presence of a thick anterior chest wall. On 
auscultation, the 1st, 2nd and 4th heart sounds were 
heard and there were no murmurs. The rest of the 
physical examination was unremarkable. A chest X-
Ray revealed Cardiomegaly and unfolding aorta while 
an electrocardiogram showed left ventricular 
hypertrophy with strain pattern. His serum urea & 
creatinine was 42mg/dl and 1.4 mg/dl respectively. 
Urinalysis revealed no abnormality; HbA1c was 5.1% 
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culminating in an estimated 7.1 million deaths a year; 
1,2
equivalent to 13% of total death worldwide.  
Although most cases of hypertension can be effectively 
treated with lifestyle changes, drugs, or both, however  
those with hypertension that is resistant to treatment 
are at the extreme end of the cardiovascular risk 
Resistant hypertension (RH) is said to occur when there 
is a failure to achieve target blood pressure goal despite 
receiving three or more anti-hypertensive drugs at 
optimal tolerable doses that includes a diuretic . This 
phenomenon is increasingly common in clinical 
practice and it is said to be present in about one in eight 
patients with hypertension. Although the exact 
prevalence of resistant hypertension is unknown, 
recent published reports have suggested that the 
prevalence ranges from 10 - 20% of general 
hypertensive population.  Patients with RH have a 3- to 
6-fold increased risk of fatal and non-fatal 
cardiovascular events compared with hypertensive 
patients whose blood pressure is maintained within 
normal levels 4-6. Patient or clinician-related factors 
may contribute to pseudo-resistant hypertension 
which include poor adherence to prescribed 
medication, suboptimal dosing of antihypertensive 
a g e n t s ,  i n a p p r o p r i a t e  c o m b i n a t i o n s  o f  
antihypertensive drugs, the white coat effect, and 
clinical inertia 4-6. Therefore management of resistant 
hypertension must begin with a careful evaluation of 
the patient to confirm the diagnosis and exclude factors 
associated with "pseudo-resistance". True resistant 
hypertension may be caused by obesity, alcohol, 
smoking, dietary sodium, concomitant use of drugs 
such as non-steroidal anti-inflammatory drugs oral 
contraceptives, sympathomimetics (decongestants, 
anorectics), adrenal steroids and antineoplastic drugs 
targeting the vascular endothelial growth factor 
(VEGF) pathway may contribute to the development of 
resistant hypertension . Other conditions such as 
obstructive sleep apnea, renal artery stenosis, renal 
parenchymal disease,
primary aldosteronism, pheochromocytoma, 
Cushing's disease, thyroid and parathyroid 
dysfunction; and aortic coarctation also contribute to 
the development of resistant hypertension4-6. Renal 
artery stenosis (RAS), which could be in form of 
atherosclerotic or fibromuscular dysplasia is one of the 
common causes of secondary hypertension and 
resistant hypertension . Anomalous renal artery is 
uncommon but can be a potential cause of resistant 
hypertension 8. Due to the presence of anomalous renal 
artery, there may be an alteration in the fluid dynamics 
that effect the respective kidney, which then develops 
kidney ischemia, thereby causes an increase in renin 






but his lipid profile were deranged ( total cholesterol– 
220mg/dl, HDL cholesterol– 40mg/dl, LDL 
cholesterol– 103mg/dl and triglycerides– 76mg/dl). 
An assessment of resistant hypertension with 
Metabolic Syndrome to rule out Renal Artery Stenosis 
(RAS) was made. He was commenced on life-style 
modification and some of his medications were 
changed such that he was now to be on; Tabs Losartan 
100mg daily (to replace lisinopril which was suspected 
to be the cause of ACEI –induced dry cough) other 
medication included Tabs Amlodipine 10mg daily, Co-
amilozide (Amiloride 5mg /Hydrochlothiazide 50 
mg), Tab Glucovance (Metformin500mg/ Glyburide 
5mg) twice daily, Tabs clopidogel 75mg daily and Tab 
Atovastatin 20mg nocte. Ultrasound examination of his 
abdomen revealed asymmetric kidney sizes (Right 
kidney 10.1cm by 5.5cm; Left kidney 5.2cm by 3cm). 
The echo patterns were normal on the right but cortical 
echogenicity was increased on the left. There was no 
dilatation of the calyces or ureters. Resistivity Index 
[RI] of left renal vessel during Doppler was 0.73. 
Conclusion was suggestive of LT Renal Artery 
Stenosis. 
Despite the modification of his antihypertensive 
regimen there was no significant change in his BP after 
2 weeks with his clinic BP as high as 190/105mmHg, his 
medications were altered again as follows to include 
addition of  Nifedipine XL 60mg morning and 30mg at 
night, Atenolol 50mg daily and Minoxidil 5mg twice 
daily while Amlodipine was discontinued. A 
Computerised Tomographic (CT) angiogram of the 
renal arteries was also done which revealed that the 
origin of the left renal artery from the aorta was 5.3cm 
distal to that of the right (Figure1),that the artery itself 
appeared foreshortened, 2cm prior to bifurcation, with 
tapering of dorsal and ventral branches (Figure 2&3). 
The left kidney was seen to be lying inferior to the right 
kidney and it was shrunken with irregular margins 
(Figure 1&2). There was also a persistent nephrogram 
phase with delay excretion in the left kidney. The right 
renal artery and kidney were within normal limit. The 
conclusion was that of Left Renal artery anomalous 
origin, distribution and bifurcation with Hypoplastic 
ectopic Left kidney. He was subsequently referred to 
urologist for possibility of Nephrectomy and renal 
denervation therapy was also discussed with him but 
declined both interventions citing fear of surgery and 
financial constraint. He was then advised to intensify 
on life style modification and adherence to medication. 
Subsequent clinic visits have been uneventful. BP 
became fairly controlled, ranging between 
148/80mmHg – 160/ 90mmHg.Discussion:
The disease burden attributable to systemic arterial 
hypertension is substantial, accounting for 62% of all 
strokes and 49% of all cases of heart disease, 
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stenting and even partial nephrectomy. Renal 
sympathetic denervation is another treatment option. 
Evidence has shown that resistant hypertention may, at 
least in part, be mediated by chronic activation of the 
sympathetic nervous system (SNS)  and the 
subsequent emergence of percutaneous sympathetic 
denervation of the renal arteries—a novel intervention 
that could stimulate a paradigm shift in the way we 
manage not only treatment-resistant systemic 
hypertension, but also a myriad of pathophysiological 
entities associated with chronically augmented SNS 
activation.  We considered that our patient might have 
probably benef i ted from Nephrectomy or  
percutaneous sympathetic denervation since he 
already had a left hypoplastic kidney which makes 
stenting or revascularisation unnecessary. But patient 
declined both interventions citing fear of surgery and 
financial constraint. Renal sympathetic denervation 
(RSDN) has been shown to be both safe and effective, 
with a durability of action apparently sustained out to 3 
years. A recent cost-effectiveness analysis of RSDN 
based on a Markov model and the Symplicity HTN-2 
has suggested it to be a cost-effective intervention for 
resistant hypertension which might also result in lower 
cardiovascular morbidity and mortality .
Conclusion
Anomalous renal arteries can be potential cause of 
resistant hypertension. We recommend Ultrasound 
scan as a screening modality for renal artery stenosis 
and anomalous renal arteries due to its being non-
invasive, free of radiation, low cost, and lack of 





dependent hypertension, and a chronic kidney disease 
condition . The most common variations of renal artery 
are excess (accessory) renal arteries and early 
bifurcation . However, anomalous renal artery can 
occur when the renal artery can arises at unusual aortic 
origin such as above the superior mesenteric artery or 
celiac trunk, in which the renal artery may be 
entrapped in the medial arcuate ligament . In this 
situation, the renal artery may be compressed and 
presented with symptoms of hypertension . The 
compression to renal artery may occur in the presence 
of low insertion of median arcuate ligament or high 
origin of the renal artery . In the case presented, 
although there was no accessory or multiple renal 
arteries but there was an anomalous left renal artery in 
terms origin. There was also ventral and dorsal 
tapering of the fore-shortened left renal artery with the 
resultant Hypoplastic left kidney (Figure2 & 3). The 
anomaly of the renal artery alone may not be the only 
contributory factor responsible for the resistant 
hypertension in this patient. The co-existing long-
standing stenosis may explain in part the ischaemia 
and subsequent hypoplasia of the left kidney and 
resistant hypertension. Obesity and excess salt intake 
might have also contributed. 
In the evaluation of the patient with suspected 
Renovascular hypertension, Duplex Doppler 
ultrasonography is an attractive option because it is a 
non-invasive test that is relatively inexpensive, does 
not require contrast medium, and can be used in 
patients with any level of renal function . As with 
many of the non-invasive imaging tests, there are 
numerous parameters and abnormal criteria indicating 
possible renovascular disease . The diagnosis of RAS is 
a frequent consideration when dealing with severe 
hypertension and renal failure; however, the choice of 
imaging modalities is controversial. Ultrasonography, 
Computed tomography angiography (CTA), and 
magnetic resonance angiography (MRA) are all used, 
and each method has its own advantages and 
drawbacks. Moreover, interpretation requires 
significant expertise. No consensus has been reached 
on the choice the imaging modality and the decision 
should be based on the level of expertise available . In 
the case presented the patient had ultrasound scan 
done which served as a screening method. The 
revelation of shrunken left kidney and Doppler finding 
prompted further investigation of Computed 
tomography angiogram (CTA) which latter revealed 
renal artery anomaly. After the establishment of a 
hemodynamically significant stenosis that results in 
hypertension there exist multiple treatment options. 
The treatment options which are to be considered for a 
hemodynamically significant stenosis of an anomalous 
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Figure 1; The left kidney was seen to be lying inferior to the right kidney and it was shrunken with
 irregular margins. (See arrow)
Figure 2; The left kidney was seen to be shrunken with irregular margins. (See arrow)
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Figure 3. The origin of the left renal artery from the 
aorta was 5.3cm distal to that of the right that the artery 
itself appeared foreshortened, 2cm prior to bifurcation, 
with tapering of dorsal and ventral branches noted 
(see arrow).
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